Cocrystal Pharma Inc
COCP
Company Profile
Business description
Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).
Contact
19805 North Creek Parkway
BothellWA98011
USAT: +1 877 262-7123
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
11
Stocks News & Analysis
stocks
Going into earnings, is Alphabet stock a buy, a sell, or fairly valued?
With the monetization of GenAI, here’s what we think of Alphabet’s stock
stocks
Going into earnings, Is Meta stock a buy, a sell, or fairly valued?
With a focus on leveraging its AI investments, here’s what we think of Meta stock.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,929.20 | 3.00 | 0.03% |
CAC 40 | 7,798.22 | 24.45 | -0.31% |
DAX 40 | 24,307.80 | 18.29 | 0.08% |
Dow JONES (US) | 44,323.07 | 19.12 | -0.04% |
FTSE 100 | 9,012.99 | 20.87 | 0.23% |
HKSE | 25,061.36 | 67.22 | 0.27% |
NASDAQ | 20,974.18 | 78.52 | 0.38% |
Nikkei 225 | 39,709.76 | 109.35 | -0.27% |
NZX 50 Index | 12,833.69 | 127.82 | -0.99% |
S&P 500 | 6,305.60 | 8.81 | 0.14% |
S&P/ASX 200 | 8,665.30 | 2.90 | -0.03% |
SSE Composite Index | 3,573.82 | 14.03 | 0.39% |